219 related articles for article (PubMed ID: 29425201)
1. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
[TBL] [Abstract][Full Text] [Related]
2. Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study.
Jurado Medina L; Chassaing E; Ballering G; Gonzalez N; Marqué L; Liehl P; Pottel H; de Boer J; Chatelain E; Zrein M; Altcheh J
Lancet Infect Dis; 2021 Aug; 21(8):1141-1150. PubMed ID: 33836157
[TBL] [Abstract][Full Text] [Related]
3. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
[TBL] [Abstract][Full Text] [Related]
4. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C
Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466
[TBL] [Abstract][Full Text] [Related]
5. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.
Sabino EC; Lee TH; Montalvo L; Nguyen ML; Leiby DA; Carrick DM; Otani MM; Vinelli E; Wright D; Stramer SL; Busch M;
Transfusion; 2013 Jun; 53(6):1257-65. PubMed ID: 23002996
[TBL] [Abstract][Full Text] [Related]
6. Polymerase chain reaction reveals Trypanosoma cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients.
Chiaramonte MG; Frank FM; Furer GM; Taranto NJ; Margni RA; Malchiodi EL
Acta Trop; 1999 Apr; 72(3):295-308. PubMed ID: 10232785
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal follow up of serological response in children treated for Chagas disease.
Moscatelli G; Moroni S; García Bournissen F; González N; Ballering G; Schijman A; Corral R; Bisio M; Freilij H; Altcheh J
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007668. PubMed ID: 31465522
[TBL] [Abstract][Full Text] [Related]
8. Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors.
Buss LF; Campos de Oliveira-da Silva L; Moreira CHV; Manuli ER; Sales FC; Morales I; Di Germanio C; de Almeida-Neto C; Bakkour S; Constable P; Pinto-Filho MM; Ribeiro AL; Busch M; Sabino EC
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008787. PubMed ID: 33108390
[TBL] [Abstract][Full Text] [Related]
9. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation.
Britto C; Cardoso MA; Vanni CM; Hasslocher-Moreno A; Xavier SS; Oelemann W; Santoro A; Pirmez C; Morel CM; Wincker P
Parasitology; 1995 Apr; 110 ( Pt 3)():241-7. PubMed ID: 7724232
[TBL] [Abstract][Full Text] [Related]
10. Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.
Murphy N; Cardinal MV; Bhattacharyya T; Enriquez GF; Macchiaverna NP; Alvedro A; Freilij H; Martinez de Salazar P; Molina I; Mertens P; Gilleman Q; Gürtler RE; Miles MA
Parasit Vectors; 2021 Oct; 14(1):543. PubMed ID: 34670602
[TBL] [Abstract][Full Text] [Related]
11. Utility of recombinant flagellar calcium-binding protein for serodiagnosis of Trypanosoma cruzi infection.
Godsel LM; Tibbetts RS; Olson CL; Chaudoir BM; Engman DM
J Clin Microbiol; 1995 Aug; 33(8):2082-5. PubMed ID: 7559952
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Elecsys Chagas Assay for Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America.
Flores-Chavez MD; Sambri V; Schottstedt V; Higuera-Escalante FA; Roessler D; Chaves M; Laengin T; Martinez A; Fleischer B
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29444836
[TBL] [Abstract][Full Text] [Related]
13. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
[TBL] [Abstract][Full Text] [Related]
14. Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.
Aguiar C; Batista AM; Pavan TB; Almeida EA; Guariento ME; Wanderley JS; Costa SC
Trop Med Int Health; 2012 Mar; 17(3):368-73. PubMed ID: 22212647
[TBL] [Abstract][Full Text] [Related]
15. Immunogenomic screening approach to identify new antigens for the serological diagnosis of chronic Chagas' disease.
Elisei RMT; Matos CS; Carvalho AMRS; Chaves AT; Medeiros FAC; Barbosa R; Marcelino AP; Dos Santos Emidio K; Coelho EAF; Duarte MC; de Oliveira Mendes TA; da Costa Rocha MO; Menezes-Souza D
Appl Microbiol Biotechnol; 2018 Jul; 102(14):6069-6080. PubMed ID: 29736822
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of congenital Trypanosoma cruzi infection: A serologic test using Shed Acute Phase Antigen (SAPA) in mother-child binomial samples.
Volta BJ; Russomando G; Bustos PL; Scollo K; De Rissio AM; Sánchez Z; Cardoni RL; Bua J
Acta Trop; 2015 Jul; 147():31-7. PubMed ID: 25847262
[TBL] [Abstract][Full Text] [Related]
17. Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.
Murcia L; Carrilero B; Ferrer F; Roig M; Franco F; Segovia M
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1819-1827. PubMed ID: 27488437
[TBL] [Abstract][Full Text] [Related]
18. Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.
Castro-Sesquen YE; Gilman RH; Mejia C; Clark DE; Choi J; Reimer-McAtee MJ; Castro R; Valencia-Ayala E; Flores J; Bowman N; Castillo-Neyra R; Torrico F; Liotta L; Bern C; Luchini A;
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004407. PubMed ID: 26919324
[TBL] [Abstract][Full Text] [Related]
19. Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.
Guzmán-Gómez D; López-Monteon A; de la Soledad Lagunes-Castro M; Álvarez-Martínez C; Hernández-Lutzon MJ; Dumonteil E; Ramos-Ligonio A
Parasit Vectors; 2015 Sep; 8():466. PubMed ID: 26384317
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening.
Chang CD; Cheng KY; Jiang LX; Salbilla VA; Haller AS; Yem AW; Bryant JD; Kirchhoff LV; Leiby DA; Schochetman G; Shah DO
Transfusion; 2006 Oct; 46(10):1737-44. PubMed ID: 17002630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
